Related Experiment Video
Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Chronic hepatitis e virus infection and treatment
Nassim Kamar1, Jacques Izopet2, Harry R Dalton3
1Department of Nephrology, Dialysis and Organ Transplantation, CHU Rangueil, Toulouse, France ; INSERM U1043, IFR-BMT, CHU Purpan, Toulouse, France ; Université Paul Sabatier, Toulouse, France.
Hepatitis E virus (HEV) infection can cause chronic liver disease in immunocompromised individuals. Treatment involves reducing immunosuppression or antiviral therapies like interferon and ribavirin.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis E virus (HEV) infection is increasingly recognized as a cause of chronic hepatitis and cirrhosis.
- Chronic HEV infections primarily affect immunosuppressed patients, including solid-organ transplant recipients, those with hematological diseases, and individuals with human immunodeficiency virus (HIV).
- HEV can also lead to extra-hepatic manifestations affecting neurological, renal, and hematological systems.
Purpose of the Study:
- To review current knowledge on chronic HEV infection in specific patient populations.
- To summarize effective treatment strategies for chronic HEV.
- To discuss HEV-associated extra-hepatic manifestations.
Main Methods:
- Literature review of studies on chronic HEV infection.
- Analysis of treatment outcomes in different patient groups.
- Compilation of reported extra-hepatic manifestations.
Main Results:
- Chronic HEV is well-established in immunosuppressed patients, particularly transplant recipients.
- Reducing immunosuppression can clear HEV in some transplant patients.
- Antiviral therapies (pegylated interferon, ribavirin) are effective for HEV eradication in non-responders and other at-risk groups.
Conclusions:
- Chronic HEV infection poses a significant challenge in immunosuppressed populations.
- Management requires tailored approaches, including immunosuppression adjustment and antiviral therapy.
- Understanding and managing extra-hepatic manifestations is crucial for comprehensive patient care.
More Related Videos
Related Concept Videos
Hepatitis
Inhibitors of Viral Protein Synthesis
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retrovirus Life Cycles

